These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11710686)

  • 61. Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
    Lin JD; Hsueh C; Chao TC; Weng HF
    Endocr Pathol; 2001; 12(1):15-21. PubMed ID: 11478264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
    Schelfhout LJ; Van Muijen GN; Fleuren GJ
    Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
    Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
    Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage.
    Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
    Pathol Res Pract; 1999; 195(6):427-33. PubMed ID: 10399184
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.
    Flanagan JN; Pineda P; Knapp PE; De Las Morenas A; Lee SL; Braverman LE
    Endocr Pract; 2008 Mar; 14(2):168-74. PubMed ID: 18308654
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CXC motif ligand 12 as a novel diagnostic marker for papillary thyroid carcinoma.
    Chung SY; Park ES; Park SY; Song JY; Ryu HS
    Head Neck; 2014 Jul; 36(7):1005-12. PubMed ID: 23784811
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions.
    Golu I; Vlad MM; Dema A; Moleriu LC; Tudor A; Iacob M; Popa O; Cornianu M
    Indian J Pathol Microbiol; 2017; 60(2):161-166. PubMed ID: 28631628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
    Schmitt AC; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential expression of CK 19 in follicular adenoma, well-differentiated tumour of uncertain malignant potential (WDT-UMP) and follicular variant of papillary carcinoma.
    Bukhari U; Sadiq S; Kehar SI
    J Pak Med Assoc; 2009 Jan; 59(1):15-8. PubMed ID: 19213370
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas.
    Trovato M; Grosso M; Vitarelli E; Ruggeri RM; Alesci S; Trimarchi F; Barresi G; Benvenga S
    Histol Histopathol; 2003 Apr; 18(2):393-9. PubMed ID: 12647789
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer?
    Yeşil C; Kandemir O; Haksever H; Dabakoğlu T
    Acta Chir Belg; 2015; 115(4):299-305. PubMed ID: 26324033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential diagnostic utility of CD56 and claudin-1 in papillary thyroid carcinoma and solitary follicular thyroid nodules.
    Abd El Atti RM; Shash LS
    J Egypt Natl Canc Inst; 2012 Dec; 24(4):175-84. PubMed ID: 23159288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Papillary and follicular neoplasms of the thyroid gland. Differential immunohistochemical staining with high-molecular-weight keratin and involucrin.
    Liberman E; Weidner N
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):42-8. PubMed ID: 10937048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors].
    Cabaret V; Vilain MO; Delobelle-Deroide A; Vanseymortier L
    Ann Pathol; 1992; 12(6):347-52. PubMed ID: 1294156
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin.
    Vaideeswar P; Pandit AA; Khilnani PH; Powar HS
    Indian J Pathol Microbiol; 1994 Apr; 37(2):165-9. PubMed ID: 7959983
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can CD10 be used as a diagnostic marker in thyroid pathology?
    Yegen G; Demir MA; Ertan Y; Nalbant OA; Tunçyürek M
    Virchows Arch; 2009 Jan; 454(1):101-5. PubMed ID: 19031085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
    Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions.
    Rau JV; Fosca M; Graziani V; Taffon C; Rocchia M; Caricato M; Pozzilli P; Onetti Muda A; Crescenzi A
    Sci Rep; 2017 Nov; 7(1):14970. PubMed ID: 29097686
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The biochemical and immunohistochemical profile of thyroid neoplasia.
    Stanta G; Carcangiu ML; Rosai J
    Pathol Annu; 1988; 23 Pt 1():129-57. PubMed ID: 2838792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.